Carlos Martin, MD
Health Economist, HTA economic evaluation and RWE applied to HTA
Ministry of Health
Dr Martín Saborido is a Health Economist working on HTA economic evaluation and RWE applied to HTA. He has been working as research associate at the Spanish Health Technology Assessment Agency mainly doing HTA reports and in the Regional HTA Unit in Madrid as health economics research fellow. Internationally, Dr Martin has been working in the Liverpool Review and Implementation Group (University of Liverpool) in UK assessing economic evaluations on behalf of NICE and doing HTA reports for the NIHR Health Technology Assessment programme. He worked as Public Health Economist in the Joint Research Centre (European Commission) developing economic evaluations in the public health frame. At the private sector. also worked at several Pharma Consultancies as RTI Health Solutions and World Health Management. In the academic ground, he has lectured Statistics, Research Methods and Economic Evaluation of Health Technologies, mentoring and guiding several PhD and MSc thesis. In 2020 gained a permanent position as Scientific Officer in the Department of Health Economics at the National School of Public Health in Madrid.
In April 2021 was appointed as Advisory member at the Ministry of Health in DG of Common NHS Portfolio and Pharmacy, working on the evaluation of new drugs reimbursement applications.
In April 2021 was appointed as Advisory member at the Ministry of Health in DG of Common NHS Portfolio and Pharmacy, working on the evaluation of new drugs reimbursement applications.